Cryofocus Medtech (Shanghai) Co (HKSE:06922) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06922 Cryofocus Medtech (Shanghai) Co Ltd HKSE:06922
61 GF Score
Price HK$2.79
GF Value HK$21.01
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Cryofocus Medtech (Shanghai) Co FFO?

FFO (Funds from operations) only applies to REITs.

HKSE:06922
61GF Score
Cryofocus Medtech (Shanghai) Co Ltd HKSE:06922
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cryofocus Medtech (Shanghai) Co (HKSE:06922) Overvalued in 2026?

Based on GuruFocus' analysis, Cryofocus Medtech (Shanghai) Co stock appears to be undervalued. The current stock price of HK$2.79 is trading 86.7% below its estimated GF Value™ of HK$21.01. GuruFocus considers Cryofocus Medtech (Shanghai) Co to be Possible Value Trap.

Key valuation signals for HKSE:06922:

  • FFO:
  • GF Value™: HK$21.01 vs. price of HK$2.79 (86.7% below fair value)
  • GF Score™: 61/100 with 3 warning signs

No single metric tells the full story. See the HKSE:06922 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cryofocus Medtech (Shanghai) Co Business Description

Address Lane 3399, Kangxin Road, Building 15, Pudong New Area, Shanghai, CHN, 200120
Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture, and sale of cryoablation minimally invasive interventional treatment technology and related medical products. The company uses liquid nitrogen as the main cryogenic source for cryotherapy systems by leveraging liquid nitrogen cryoablation technology and flexible catheter technology. The products offered by the company include: Bladder Cryoablation System, Pulmonary Nodule Localization Needle, and Endoscopic Clip for Anastomosis, among others. Geographically, the company's revenue is generated from the sale of medical consumables and devices in the Chinese Mainland.
61GF Score

Get the complete analysis for HKSE:06922

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.79
Price
HK$21.01
GF Value